OREX

Orexigen Therapeutics, Inc. News Headlines

$5.005
*  
0.225
4.71%
Get OREX Alerts
*Delayed - data as of Sep. 17, 2014 15:23 ET  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OREX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Orexigen Therapeutics Wins Contrave Approval But Investors Should Stay Away
9/16/2014 2:01:00 PM - Seeking Alpha

InsiderInsights.com Daily Round Up 9/15/14: Tallgrass Energy Partners, Mercer, Republic Services, Armada Hoffler Properties
9/16/2014 12:57:00 PM - Seeking Alpha

Doc Offers Glimpse Into Arena Pharma Weight-Loss Combination Therapy
9/16/2014 9:48:00 AM - TheStreet

Orexigen Falls After Approval - Why?
9/15/2014 2:25:00 PM - Seeking Alpha

Arena And Vivus Ruined The FDA Approval Run Up For Orexigen
9/13/2014 8:02:00 PM - Seeking Alpha

2 New Diet Drugs Coming Soon?
9/13/2014 2:05:03 PM - Motley Fool

Novo Gets Positive Vote From FDA For Anti-Obesity Treatment - Still A Long Road Ahead
9/12/2014 5:18:00 PM - Seeking Alpha

Novo Nordisk's Saxenda Gets Positive Opinion for Obesity - Analyst Blog
9/12/2014 5:10:00 PM - Zacks.com

Orexigen: Poised To Grab A Large Part Of The Weight Loss Market
9/12/2014 1:40:00 PM - Seeking Alpha

Belviq Advertising Sees Major Shift
9/12/2014 1:22:00 PM - Seeking Alpha

Surprising New Competitor: Should Arena Pharmaceuticals, Inc. and Orexigen Therapeutics, Inc. Be Afr
9/12/2014 9:09:40 AM - Motley Fool

A New Nifty Fifty States Stock Index
9/12/2014 12:46:00 AM - Seeking Alpha

FDA Approves Orexigen Therapeutics Inc.'s Goldilocks Obesity Drug
9/11/2014 4:46:01 PM - Motley Fool

How Will Orexigen Therapeutics (OREX) Stock Respond to FDA's Contrave Approval?
9/11/2014 4:10:00 PM - TheStreet

Sector Update: Health Care Stocks Sit Out Late Rise For Stocks; Orexigen Slammed After FDA 'Black Label'
9/11/2014 4:04:37 PM - MT Newswires

Sector Update: Health Care
9/11/2014 4:02:39 PM - MT Newswires

Skinny pill approved!
9/11/2014 11:32:00 AM - Market Intelligence Center

Orexigen's Contrave Approved: What It Means To Arena
9/11/2014 10:02:00 AM - Seeking Alpha

FDA Approves Orexigen's Contrave For Obesity Treatment
9/11/2014 9:22:00 AM - Seeking Alpha

Sector Update: Health Care
9/11/2014 8:38:24 AM - MT Newswires

Sector Update: Healthcare shares Mixed in Pre-Market Trade
9/11/2014 8:37:28 AM - MT Newswires

FDA Approves Orexigen's Diet Drug Contrave
9/11/2014 8:35:00 AM - Dow Jones Business News

FDA Okays Orexigen Therapeutics' Weight-Loss Drug Contrave
9/11/2014 6:07:00 AM - RTT News

Why Arena Pharmaceuticals, Inc. Stock Crashed By 31% in 2014
9/9/2014 9:45:02 AM - Motley Fool

Orexigen Gets Weight Loss Drug Patent, May See Runup Into Approval Decision
9/5/2014 11:46:00 AM - Seeking Alpha